EU regulator recommends approval of Pfizer-BioNTech COVID-19 vaccine for kids 5-11
Nov 25, 2021
The European Union’s drug regulator on Thursday recommended approval of Pfizer’s coronavirus vaccine for use on children from five to 11 years old, clearing a path for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent.
It is the first time the European Medicines Agency has cleared a COVID-19 vaccine for use in young children. The agency said it “recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged five to 11.”
A news release outlining the decision said a committee concluded that the benefits of the vaccine in children aged five to 11 “outweigh the risks, particularly in those with conditions that increase the risk of severe COVID-19.”
While final approval is up to the European Commission, it typically follows EMA recommendations.
Read more: https://www.cbc.ca/news/world/coronavirus-covid19-canada-world-nov25-2021-1.6261977